ORIGINAL RESEARCH article
Front. Cardiovasc. Med.
Sec. Coronary Artery Disease
This article is part of the Research TopicNovel Role and Mechanisms of Inflammation in Myocardial InfarctionView all 8 articles
Prognostic Value of the Neutrophil Percentage-to-Albumin Ratio for Mortality in ICU Patients With Myocardial Infarction: A Retrospective Cohort and Machine Learning Analysis
Provisionally accepted- 1Fujian University of Traditional Chinese Medicine, Fuzhou, Fujian Province, China
- 2Affiliated Xiamen Hospital of Traditional Chinese Medicine, Fujian University of Traditional Chinese Medicine, Xiamen, China
Select one of your emails
You have multiple emails registered with Frontiers:
Notify me on publication
Please enter your email address:
If you already have an account, please login
You don't have a Frontiers account ? You can register here
Background Although the neutrophil percentage-to-albumin ratio (NPAR) has shown prognostic value in multiple clinical conditions, its prognostic accuracy for myocardial infarction (MI) patients receiving intensive care has yet to be clearly defined. To our knowledge, this study is the first to comprehensively evaluate the prognostic role of NPAR in ICU-admitted MI patients, integrating both conventional Cox regression and machine learning approaches to address an existing gap between general MI cohorts and critically ill populations. Method Using data from the MIMIC-IV v3.1 database, we retrospectively included 1,759 ICU-admitted MI patients and calculated NPAR at admission. Primary and secondary outcomes were 30-day and 360-day all-cause mortality, respectively. Kaplan–Meier curves and log-rank tests compared survival across tertiles. Multivariate Cox models assessed associations, with restricted cubic splines evaluating nonlinearity. Machine learning models incorporating NPAR were developed to predict 30-day mortality, and model performance was assessed using the area under the receiver operating characteristic curve (AUC). Result The 30-day and 360-day all-cause mortality rates were 24% and 38%, respectively. Kaplan–Meier analysis revealed significantly lower survival probabilities in patients with higher NPAR levels. Adjusted Cox regression showed that those in the highest NPAR tertile had an increased risk of 30-day (HR: 2.03, 95% CI: 1.51–2.73, p < 0.001) and 360-day (HR: 1.81, 95% CI: 1.45–2.26, p < 0.001) mortality. Machine learning models incorporating NPAR achieved an AUC of up to 0.81 for predicting 30-day death. Conclusion The NPAR serves as an independent predictor of mortality at 30 and 360 days in MI patients admitted to the intensive care unit (ICU). When integrated into machine learning models, NPAR enhances predictive accuracy. These results indicate that NPAR serves as an independent predictor of short-and long-term mortality in ICU-admitted MI patients. Given its simplicity and accessibility from routine laboratory tests, NPAR can be feasibly incorporated into clinical decision-making and risk stratification protocols in critical care settings to facilitate individualized risk assessment and improve outcomes.
Keywords: Neutrophil percentage-to-albumin ratio, Myocardial Infarction, All-causemortality, machine learning, MIMIC-IV database
Received: 19 May 2025; Accepted: 05 Dec 2025.
Copyright: © 2025 Cao, Lin, Xu, Zhang, Chen, Chen and Wang. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) or licensor are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
* Correspondence:
Jun Chen
Yunsu Wang
Disclaimer: All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.
